Company intelligence / Profile preview

New Wave Ventures

Manchester, England, United Kingdomnwventures.co.uk ↗

Ownership: Private
Development stage: Other

Overview

New Wave Biotech develops AI-driven simulation software ("Bioprocess Foresight") to optimize and accelerate R&D in synthetic biology and biomanufacturing. Their platform allows companies to model downstream processes virtually, reducing time/cost of physical experiments and improving scalability of new bio-based products. The company has raised over €1.2 million in funding from investors including EIT Food and Innovate UK. No clinical results as they do not develop therapeutics themselves.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

EIT Food (investor/supporter)Innovate UK (investor/supporter)

Beyond the preview

Go deeper on New Wave Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Wave Ventures.

Explore the full profile